Main Menu

News

/News

Multiple myeloma treatment advances: What health execs should know

Multiple myeloma is a rare cancer, representing about 1.8% of all cancers combined, according to the National Cancer Institute. About 30,000 new cases are expected in the U.S. in 2017. It is more common in men than women, among individuals of African-American descent, and those aged 65 years and older. The SEER Cancer Statistics Review, [...]

June 26th, 2017|News|

My First Big Dam Post

So, first I would like to say that bicycling is a great joy in my life, but I find that I really cannot tell you that.  I am aging, and it is killing my body.  Nonetheless, let’s get this blog thing going. Besides being a middle-aged Welsh myeloma doctor from London, now living for almost [...]

June 16th, 2017|Big Dam Bridge 100, News|

Honors for Man & Woman for fighting blood cancer

Nadine Baxter, president of the Leukemia & Lymphoma Society board, lost her mother to acute myeloblastic leukemia within three days of her diagnosis in 2013. Baxter is gearing up for the society’s Man & Woman of the Year Grand Finale Celebration, to be held Friday. Nadine Baxter has spent the last 17 of [...]

April 18th, 2017|News, Uncategorized|

The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute

Clues to be found in more personalized treatment for multiple myeloma can be found in the genetics of myeloma in each individual patient. Dr. Gareth Morgan and the UAMS Myeloma Institute in collaboration with the Dana Farber Cancer Institute and other institutions are working to collect genomic data from myeloma patients with the goal of [...]

April 5th, 2017|News, Uncategorized|

Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment

Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component parts into either the blood or urine, hence called non-secretory myeloma. Some non-secretory myeloma patients [...]

March 30th, 2017|News, Uncategorized|

Faces of UAMS: Brian Walker, Ph.D.

Brian Walker is the director of research for the UAMS Myeloma Institute. March is Multiple Myeloma Awareness Month, and Walker discusses what that special focus on myeloma means, his research and how the UAMS Myeloma Institute’s world-leading status for the research and treatment of it drew him to accept his position here more than a [...]

March 21st, 2017|News, Uncategorized|

Understanding Multiple Myeloma: Dr. Faith Davis from UAMS

March 21st, 2017|News, Uncategorized|

Dr. Frits Van Rhee with UAMS joins Fox 16 Good Day

Dr. Frits Van Rhee with UAMS joins Fox 16 Good Day to tell us more about multiple myeloma and how it's treated. Watch video below: http://www.fox16.com/klrt-good-day/myeloma-awareness-month/667936670  

March 7th, 2017|News, Uncategorized|

U.S. Ambassador Chooses UAMS Myeloma Institute

March 2, 2017 | Ambassador Ruth A. Davis traveled the world as a U.S. diplomat during her 40 years with the U.S. Foreign Service. But when she learned she had a relapse of multiple myeloma, a cancer of plasma cells in the blood, she headed to Arkansas and the UAMS Myeloma Institute. “I’ve often had [...]

March 2nd, 2017|Featured, Medical News, News, Uncategorized|

March 2017 DAISY Award

Melissa Thomas, RN III – The Myeloma Institute Congratulations to Melissa Thomas, RN III for being selected as the DAISY Award recipient for the month of March! Melissa works in The Myeloma Institute and was nominated by a co-worker who was also a patient.  The nomination below reflects how Melissa impacted her life in a [...]

March 1st, 2017|News, Uncategorized|